The role of Smad7 in cutaneous wound healing

Min-Feng Wu1, Qing-Yu Zeng2, Jian-Hua Huang1

  • 1Department of Dermatology, Huadong Hospital, Fudan University, Shanghai, China.

Insights

Smad7, an antagonist of transforming growth factor-beta (TGF-β), promotes chronic wound healing by regulating cell growth and cytokines. Understanding Smad7

Area of Science:

  • Regenerative Medicine
  • Molecular Biology
  • Dermatology

Background:

  • Chronic refractory wounds exhibit delayed healing and high recurrence due to tissue defects and necrosis.
  • Current therapeutics lack efficacy, necessitating novel approaches to accelerate granulation and reduce recurrence.
  • The pathogenesis involves complex signaling pathways, notably the transforming growth factor-beta (TGF-β)/Smad7 axis.

Purpose of the Study:

  • To elucidate the precise functions and mechanisms of Smad7 in regulating wound healing.
  • To explore Smad7's potential as a therapeutic target for chronic wounds.

Main Methods:

  • Literature review focusing on the TGF-β/Smad7 signaling pathway in wound healing.
  • Analysis of Smad7's role as a TGF-β antagonist.
  • Examination of Smad7's influence on cytokines, cell growth, differentiation, and apoptosis.

Main Results:

  • Smad7 acts as a critical antagonist of TGF-β, inhibiting its activation.
  • Smad7 positively regulates cytokines essential for wound repair.
  • Smad7 controls cellular processes including growth, differentiation, and apoptosis, thereby promoting healing.

Conclusions:

  • The TGF-β/Smad7 axis is pivotal in chronic wound healing.
  • Smad7 demonstrates significant therapeutic potential for treating refractory wounds.
  • Targeting Smad7 offers a promising strategy to accelerate wound healing and prevent recurrence.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.8K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.1K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.3K
Phases of Wound Repair01:28

Phases of Wound Repair

Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
7.4K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.0K